Management of steroid-dependent ulcerative colitis: immunomodulatory agents, biologics, or surgery?

Clin Gastroenterol Hepatol. 2007 Jun;5(6):668-71. doi: 10.1016/j.cgh.2007.03.028.
No abstract available

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Algorithms
  • Antibodies, Monoclonal / therapeutic use*
  • Azathioprine / administration & dosage
  • Azathioprine / therapeutic use
  • Colitis, Ulcerative / drug therapy*
  • Colitis, Ulcerative / surgery*
  • Colonic Pouches
  • Female
  • Glucocorticoids / therapeutic use
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / therapeutic use
  • Infliximab
  • Mercaptopurine / administration & dosage
  • Mercaptopurine / therapeutic use
  • Practice Guidelines as Topic
  • Proctocolectomy, Restorative
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal
  • Glucocorticoids
  • Immunosuppressive Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab
  • Mercaptopurine
  • Azathioprine